IM Cannabis (IMCC) Cash from Restructuring (2020 - 2025)
IM Cannabis' (IMCC) quarterly Cash from Restructuring came in at -$6969.2 in Q1 2025, up 37.39% year-on-year from -$5072.4 in Q1 2024, and up 49.96% quarter-over-quarter from -$13928.0 in Q3 2024.
IM Cannabis (IMCC) Cash from Restructuring (2020 - 2025) Analysis & Trends
IM Cannabis' Cash from Restructuring history runs 6 years deep, the most recent figure standing at -$6969.2 for Q1 2025.
- On a quarterly basis, Cash from Restructuring rose 37.39% year-over-year to -$6969.2 in Q1 2025; TTM through Mar 2025 was -$39340.3, a 13.06% increase from a year earlier, with the FY2022 full-year figure at $6.7 million, up 726.66% from the prior year.
- Cash from Restructuring rose to -$6969.2 in Q1 2025 per IMCC's latest filing, from -$13928.0 in the prior quarter.
- Across five years, Cash from Restructuring topped out at $7.4 million in Q3 2022 and bottomed at -$3.1 million in Q2 2022.
- The 5-year median for Cash from Restructuring is -$11787.2 (2022), against an average of $370785.8.
- Across the five-year window, Cash from Restructuring tumbled 2540.41% in 2021 and jumped 19266.11% in 2022, its largest moves.
- Year by year, Cash from Restructuring stood at -$344307.9 in 2021, then jumped by 96.58% to -$11787.2 in 2022, then surged by 36.72% to -$7459.3 in 2023, then plunged by 86.72% to -$13928.0 in 2024, then soared by 49.96% to -$6969.2 in 2025.
- Per Business Quant, the three latest IMCC Cash from Restructuring figures stand at -$6969.2 (Q1 2025), -$13928.0 (Q3 2024), and -$7311.4 (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -6,969.16 |
| Sep 30, 2024 | -13,928.01 |
| Jun 30, 2024 | -7,311.41 |
| Mar 31, 2024 | -11,131.70 |
| Sep 30, 2023 | -7,459.30 |
| Jun 30, 2023 | -235,991.43 |
| Mar 31, 2023 | 209,334.07 |
| Dec 31, 2022 | -11,787.25 |
| Sep 30, 2022 | 7.39 Mn |
| Jun 30, 2022 | -3.08 Mn |
| Mar 31, 2022 | 2.42 Mn |
| Dec 31, 2021 | -344,307.86 |
| Sep 30, 2021 | -266,127.12 |
| Jun 30, 2021 | -457,202.26 |
| Mar 31, 2021 | -12,641.59 |
| Dec 31, 2020 | -13,039.93 |
| Mar 31, 2020 | -12,680.21 |